Andriole GL, Crawford ED, Grubb RL, et al. (2012) Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. Journal of the National Cancer Institute 104: 125-132.
Crawford, E., Black, L., and Eaddy, M. et al. (2010). A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Prostate Cancer and Prostatic Diseases 13: 162-167.
Etzioni R, Penson DF, Legler JM, et al. (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. Journal of the National Cancer Institute 94: 981-990.
Gralnek, I. M. Dulai, G. S. Fennerty, M. B. et al. (2006) Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clinical Gastroenterology and Hepatology 4: 1452-1458.
Loeb S, Vellekoop A, Ahmed HU, et al. (2013). Systematic review of complications of prostate biopsy. European Urology 64: 876-892.
Loeb S, Vonesh EF, Metter EJ, et al. (2011) What is the true Number Needed to Screen and treat to save a life with Prostate-Specific Antigen testing? Journal of Clinical Oncology 29: 464-467.
Qadeer MA, Phillips CO, Lopez AR, et al. (2006) Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: A meta-analysis of randomized controlled trials. The American Journal of Gastroenterology 101: 2646.